|
1
|
Cramer P, Armache KJ, Baumli S, Benkert S, Brueckner F, Buchen C, Damsma GE, Dengl S, Geiger SR, Jasiak AJ, et al: Structure of eukaryotic RNA polymerases. Annu Rev Biophys. 37:337–352. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cramer P, Bushnell DA and Kornberg RD: Structural basis of transcription: RNA polymerase II at 2.8 angstrom resolution. Science. 292:1863–1876. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Acker J, de Graaff M, Cheynel I, Khazak V, Kedinger C and Vigneron M: Interactions between the human RNA polymerase II subunits. J Biol Chem. 272:16815–16821. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kolodziej PA and Young RA: Mutations in the three largest subunits of yeast RNA polymerase II that affect enzyme assembly. Mol Cell Biol. 11:4669–4678. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cramer P: RNA polymerase II structure: From core to functional complexes. Curr Opin Genet Dev. 14:218–226. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schier AC and Taatjes DJ: Structure and mechanism of the RNA polymerase II transcription machinery. Genes Dev. 34:465–488. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gillis A and Berry S: Global control of RNA polymerase II. Biochim Biophys Acta Gene Regul Mech. 1867:1950242024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ciesla M, Turowski TW, Nowotny M, Tollervey D and Boguta M: The expression of Rpb10, a small subunit common to RNA polymerases, is modulated by the R3H domain-containing Rbs1 protein and the Upf1 helicase. Nucleic Acids Res. 48:12252–12268. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ryu J and Lee C: RNA polymerase subunits and ribosomal proteins: An overview and their genetic impact on complex human traits. Front Biosci (Landmark Ed). 29:1852024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo Z and Stiller JW: Comparative genomics and evolution of proteins associated with RNA polymerase II C-terminal domain. Mol Biol Evol. 22:2166–2178. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Purkayastha D and Karmodiya K: RNA polymerase II evolution and adaptations: Insights from Plasmodium and other parasitic protists. Infect Genet Evol. 115:1055052023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A, et al: Highly accurate protein structure prediction with AlphaFold. Nature. 596:583–589. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sawadogo M and Sentenac A: RNA polymerase B (II) and general transcription factors. Annu Rev Biochem. 59:711–754. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Myer VE and Young RA: RNA polymerase II holoenzymes and subcomplexes. J Biol Chem. 273:27757–27760. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dieci G, Fiorino G, Castelnuovo M, Teichmann M and Pagano A: The expanding RNA polymerase III transcriptome. Trends Genet. 23:614–622. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sadurni MM and Saponaro M: Deregulations of RNA Pol II subunits in cancer. Appl Biosci. 2:459–476. 2023. View Article : Google Scholar
|
|
17
|
Chen J, Xu J, Li L, Yuan Y, Jiang J and Sun Y: Propofol regulates the progression of hepatocellular carcinoma via the POLR2L/TGF-beta signaling pathway. Transl Cancer Res. 13:2266–2281. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lv Z, Wu X, Lu P, Xu X, Wang J, Zhang C, Liu W, Gao Y, Lu C, Zhang Y and Kou H: POLE2 knockdown suppresses lymphoma progression via downregulating Wnt/beta-catenin signaling pathway. Mol Cell Biochem. 479:487–497. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roszkowska M: Multilevel mechanisms of cancer drug resistance. Int J Mol Sci. 25:124022024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khan SU, Fatima K, Aisha S and Malik F: Unveiling the mechanisms and challenges of cancer drug resistance. Cell Commun Signal. 22:1092024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei L, Levine AS and Lan L: Transcription-coupled homologous recombination after oxidative damage. DNA Repair (Amst). 44:76–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dumay-Odelot H, Durrieu-Gaillard S, Da Silva D, Roeder RG and Teichmann M: Cell growth- and differentiation-dependent regulation of RNA polymerase III transcription. Cell Cycle. 9:3687–3699. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Acker J, Murroni O, Mattei MG, Kedinger C and Vigneron M: The gene (POLR2L) encoding the hRPB7.6 subunit of human RNA polymerase. Genomics. 32:86–90. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cramer P: Multisubunit RNA polymerases. Curr Opin Struct Biol. 12:89–97. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mackereth CD, Arrowsmith CH, Edwards AM and McIntosh LP: Zinc-bundle structure of the essential RNA polymerase subunit RPB10 from Methanobacterium thermoautotrophicum. Proc Natl Acad Sci USA. 97:6316–6321. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sainsbury S, Bernecky C and Cramer P: Structural basis of transcription initiation by RNA polymerase II. Nat Rev Mol Cell Biol. 16:129–143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Donaldson IM and Friesen JD: Zinc stoichiometry of yeast RNA polymerase II and characterization of mutations in the zinc-binding domain of the largest subunit. J Biol Chem. 275:13780–13788. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, et al: Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 7:5392011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kontermann R and Bautz EK: Similarity between subunit 8 of yeast RNA polymerase II (RPB8) and the second-largest subunits of eukaryotic RNA polymerases. Nucleic Acids Res. 20:52311992. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sakurai H and Ishihama A: Transcription organization and mRNA levels of the genes for all 12 subunits of the fission yeast RNA polymerase II. Genes Cells. 6:25–36. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rubbi L, Labarre-Mariotte S, Chedin S and Thuriaux P: Functional characterization of ABC10alpha, an essential polypeptide shared by all three forms of eukaryotic DNA-dependent RNA polymerases. J Biol Chem. 274:31485–31492. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cramer P, Bushnell DA, Fu J, Gnatt AL, Maier-Davis B, Thompson NE, Burgess RR, Edwards AM, David PR and Kornberg RD: Architecture of RNA polymerase II and implications for the transcription mechanism. Science. 288:640–649. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Buratowski S: Progression through the RNA polymerase II CTD cycle. Mol Cell. 36:541–546. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shpakovski GV, Acker J, Wintzerith M, Lacroix JF, Thuriaux P and Vigneron M: Four subunits that are shared by the three classes of RNA polymerase are functionally interchangeable between Homo sapiens and Saccharomyces cerevisiae. Mol Cell Biol. 15:4702–4710. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Turowski TW and Boguta M: Specific features of RNA polymerases I and III: Structure and assembly. Front Mol Biosci. 8:6800902021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Juang U, Lee S, Gwon S, Jung W, Nguyen H, Huang Q, Lee B, Kwon SH, Kim SH, Kim IS, et al: Enhancement of renal fibrosis in PHF20 transgenic mice. Toxicol Res. 41:71–80. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Trinh V, Langelier MF, Archambault J and Coulombe B: Structural perspective on mutations affecting the function of multisubunit RNA polymerases. Microbiol Mol Biol Rev. 70:12–36. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou D, Li X, Zhao H, Sun B, Liu A, Han X, Cui Z and Yuan L: Combining multi-dimensional data to identify a key signature (gene and miRNA) of cisplatin-resistant gastric cancer. J Cell Biochem. 119:6997–7008. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Woychik NA and Young RA: RNA polymerase II subunit RPB10 is essential for yeast cell viability. J Biol Chem. 268:122301993. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Korkhin Y, Unligil UM, Littlefield O, Nelson PJ, Stuart DI, Sigler PB, Bell SD and Abrescia NG: Evolution of complex RNA polymerases: The complete archaeal RNA polymerase structure. PLoS Biol. 7:e10001022009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Garrido-Godino AI, Gupta I, Pelechano V and Navarro F: RNA Pol II assembly affects ncRNA expression. Int J Mol Sci. 25:5072023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gagnidze K and Pfaff DW: Epigenetic mechanisms: DNA methylation and histone protein modification. In: Neuroscience in the 21st Century: From Basic to Clinical. Pfaff DW, Volkow ND and Rubenstein J: Springer; New York, New York, NY: pp. 1–40. 2020
|
|
43
|
Robertson KD: Epigenetic mechanisms of gene regulation. DNA methylation and cancer therapy. Springer US; Boston, MA: pp. 13–30. 2005, View Article : Google Scholar
|
|
44
|
Juang U, Gwon S, Jung W, Nguyen H, Huang Q, Lee S, Lee B, Kwon SH, Kim SH and Park J: Exploring the various functions of PHD finger protein 20: Beyond the unknown. Toxicol Res. 41:1–11. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yao F, Zhan Y, Li C, Lu Y, Chen J, Deng J, Wu Z, Li Q, Song Y, Chen B, et al: Single-Cell RNA sequencing reveals the role of phosphorylation-related genes in hepatocellular carcinoma stem cells. Front Cell Dev Biol. 9:7342872021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lu Y, Wang S, Chi T, Zhao Y, Guo H, Wang H and Feng L: DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma. Sci Rep. 13:189782023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kettenberger H, Armache KJ and Cramer P: Complete RNA polymerase II elongation complex structure and its interactions with NTP and TFIIS. Mol Cell. 16:955–965. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Woychik NA and Young RA: RNA polymerase II subunit RPB10 is essential for yeast cell viability. J Biol Chem. 265:17816–17819. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hu Y and Liu B: Roles of zinc-binding domain of bacterial RNA polymerase in transcription. Trends Biochem Sci. 47:710–724. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Li Y, Huang J, Zhu J, Bao L, Wang H, Jiang Y, Tian K, Wang R, Zheng H, Duan W, et al: Targeted protein degradation reveals RNA Pol II heterogeneity and functional diversity. Mol Cell. 82:3943–3959.e3911. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ehara H, Yokoyama T, Shigematsu H, Yokoyama S, Shirouzu M and Sekine SI: Structure of the complete elongation complex of RNA polymerase II with basal factors. Science. 357:921–924. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH and Kim VN: MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23:4051–4060. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jia W, Chen W and Kang J: The functions of microRNAs and long non-coding RNAs in embryonic and induced pluripotent stem cells. Genomics Proteomics Bioinformatics. 11:275–283. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mattick JS, Amaral PP, Carninci P, Capenter S, Chang HY, Chen LL, Chen R, Dean C, Dinger ME, Fitzgerald KA, et al: Long non-coding RNAs: Definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 24:430–447. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang J, Ye C, Xiong H, Shen Y, Lu Y, Zhou J and Wang L: Dysregulation of long non-coding RNA in breast cancer: An overview of mechanism and clinical implication. Oncotarget. 8:5508–5522. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wei DM, Jiang MT, Lin P, Yang H, Dang YW, Yu Q, Liao DY, Luo DZ and Chen G: Potential ceRNA networks involved in autophagy suppression of pancreatic cancer caused by chloroquine diphosphate: A study based on differentially-expressed circRNAs, lncRNAs, miRNAs and mRNAs. Int J Oncol. 54:600–626. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zou RC, Shi ZT, Xiao SF, Ke Y, Tang HR, Wu TG, Guo ZT, Ni F, An S and Wang L: Co-expression analysis and ceRNA network reveal eight novel potential lncRNA biomarkers in hepatocellular carcinoma. PeerJ. 7:e81012019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Cui X, Li C, Ding J, Yao Z, Zhao T, Guo J, Wang Y and Li J: Establishing a proteomics-based signature of AKR1C3-related genes for predicting the prognosis of prostate cancer. Int J Mol Sci. 24:45132023. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang D, Xu X, Wei Y, Chen X, Li G, Lu Z, Zhang X, Ren X, Wang S and Qin C: Prognostic role of DNA damage response genes mutations and their association with the sensitivity of olaparib in prostate cancer patients. Cancer Control. 29:107327482211294512022. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang H and Ryu WS: Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: Implications for immune evasion. PLoS Pathog. 6:e10009862010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
de Gruijter NM, Jebson B and Rosser EC: Cytokine production by human B cells: Role in health and autoimmune disease. Clin Exp Immunol. 210:253–262. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yasmeen F, Pirzada RH, Ahmad B, Choi B and Choi S: Understanding autoimmunity: Mechanisms, predisposing factors, and cytokine therapies. Int J Mol Sci. 25:76662024. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zhang H, Dai Z, Wu W, Wang Z, Zhang N, Zhang L, Zeng WJ, Liu Z and Cheng Q: Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer. J Exp Clin Cancer Res. 40:1842021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wojtukiewicz MZ, Rek MM, Karpowicz K, Górska M, Polityńska B, Wojtukiewicz AM, Moniuszko M, Radziwon P, Tucker SC and Honn KV: Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new challenge for internists and general practitioners. Cancer Metastasis Rev. 40:949–982. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Bai Y, Wang W and Wang J: Targeting DNA repair pathways: Mechanisms and potential applications in cancer therapy. Genome Instability & Disease. 1:318–338. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Talukdar PD and Chatterji U: Transcriptional co-activators: Emerging roles in signaling pathways and potential therapeutic targets for diseases. Signal Transduct Target Ther. 8:4272023. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hartman J, Khanna V, Habib A, Farrokhyar F, Memon M and Adili A: Perioperative systemic glucocorticoids in total hip and knee arthroplasty: A systematic review of outcomes. J Orthop. 14:294–301. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Li M, Liu Z, Wang J, Liu H, Gong H, Li S, Jia M and Mao Q: Systematic analysis identifies a specific RNA-binding protein-related gene model for prognostication and risk-adjustment in HBV-related hepatocellular carcinoma. Front Genet. 12:7073052021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sun J, Zhao J, Yang Z, Zhou Z and Lu P: Identification of gene signatures and potential therapeutic targets for acquired chemotherapy resistance in gastric cancer patients. J Gastrointest Oncol. 12:407–422. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Cai J, Chen Z, Chen X, Huang H, Lin X and Miao B: Coexpression network analysis identifies a novel Nine-RNA signature to improve prognostic prediction for prostate cancer patients. Biomed Res Int. 2020:42642912020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhang S, Qin O, Wu S, Xu H, Huang W and Hailiang S: A pyrimidine metabolism-related signature for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma by integrating analyses. Aging (Albany NY). 16:5545–5566. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Osaki M, Oshimura M and Ito H: PI3K-Akt pathway: Its functions and alterations in human cancer. Apoptosis. 9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, et al: PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 22:1382023. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Sun EJ, Wankell M, Palamuthusingam P, McFarlane C and Hebbard L: Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Biomedicines. 9:16392021. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yang J, Nie J, Ma X, Wei Y, Peng Y and Wei X: Targeting PI3K in cancer: Mechanisms and advances in clinical trials. Mol Cancer. 18:262019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y, Dong Q and Wei X: Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol. 17:462024. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhang Y and Wang X: Targeting the Wnt/β-catenin signaling pathway in cancer. J Hematol Oncol. 13:1652020. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wang C, Chen Q and Xu H: Wnt/β-catenin signal transduction pathway in prostate cancer and associated drug resistance. Discov Oncol. 12:402021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Parsana P, Amend SR, Hernandez J, Pienta KJ and Battle A: Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration. BMC Cancer. 17:4472017. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Imodoye SO and Adedokun KA: EMT-induced immune evasion: Connecting the dots from mechanisms to therapy. Clin Exp Med. 23:4265–4287. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ma Q, Hao S, Hong W, Tergaonkar V, Sethi G, Tian Y and Duan C: Versatile function of NF-kB in inflammation and cancer. Exp Hematol Oncol. 13:682024. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Hoesel B and Schmid JA: The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Park MH and Hong JT: Roles of NF-κB in cancer and inflammatory diseases and their therapeutic approaches. Cells. 5:152016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Chen B, Cai T, Huang C, Zang X, Sun L, Guo S, Wang Q, Chen Z, Zhao Y, Han Z, et al: G6PD-NF-κB-HGF signal in gastric cancer-associated mesenchymal stem cells promotes the proliferation and metastasis of gastric cancer cells by upregulating the expression of HK2. Front Oncol. 11:6487062021. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Di Carlo E and Sorrentino C: State of the art CRISPR-based strategies for cancer diagnostics and treatment. Biomark Res. 12:1562024. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Ortega MA, Boaru DL, De Leon-Oliva D, Fraile-Martinez O, García-Montero C, Rios L, Garrido-Gil MJ, Barrena-Blázquez S, Minaya-Bravo AM, Rios-Parra A, et al: PD-1/PD-L1 axis: Implications in immune regulation, cancer progression, and translational applications. J Mol Med (Berl). 102:987–1000. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Mpiima DP, Salongo GW, Lugobe H, Ssemujju A, Mulisya OM, Masinda A, Twizerimana H and Ngonzi J: Association between prior chlamydia trachomatis infection and ectopic pregnancy at a tertiary care hospital in South Western Uganda. Obstet Gynecol Int. 2018:48273532018. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Seow H, O'Leary E, Perez R and Tanuseputro P: Access to palliative care by disease trajectory: A population-based cohort of Ontario decedents. BMJ Open. 8:e0211472018. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Krishna SS, Majumdar I and Grishin NV: Structural classification of zinc fingers: Survey and summary. Nucleic Acids Res. 31:532–550. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Tubon TC, Tansey WP and Herr W: A nonconserved surface of the TFIIB zinc ribbon domain plays a direct role in RNA polymerase II recruitment. Mol Cell Biol. 24:2863–2874. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Masud T, Soong C, Xu H, Biele J, Bjornson S, McKinney S and Aparicio S: Ubiquitin-mediated DNA damage response is synthetic lethal with G-quadruplex stabilizer CX-5461. Sci Rep. 11:98122021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Devaux S, Kelly S, Lecordier L, Wickstead B, Perez-Morga D, Pays E, Vanhamme L and Gull K: Diversification of function by different isoforms of conventionally shared RNA polymerase subunits. Mol Biol Cell. 18:1293–1301. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Coulombe B and Burton ZF: DNA bending and wrapping around RNA polymerase: A ‘revolutionary’ model describing transcriptional mechanisms. Microbiol Mol Biol Rev. 63:457–478. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Garrido-Godino AI, Gutierrez-Santiago F and Navarro F: Biogenesis of RNA polymerases in yeast. Front Mol Biosci. 8:6693002021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Singh H: Targeting RNA polymerase II mediator subunits in cancer therapy. Proc Natl Acad Sci USA. 118:e21001151182021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Rodriguez-Berriguete G, Ranzani M, Prevo R, Puliyadi R, Machado N, Bolland HR, Millar V, Ebner D, Boursier M, Cerutti A, et al: Small-molecule poltheta inhibitors provide safe and effective tumor radiosensitization in preclinical models. Clin Cancer Res. 29:1631–1642. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhang Y, Wang D, Peng M, Tang L, Ouyang J, Xiong F, Guo C, Tang Y, Zhou Y, Liao Q, et al: Single-cell RNA sequencing in cancer research. J Exp Clin Cancer Res. 40:812021. View Article : Google Scholar : PubMed/NCBI
|
